Why drug patent protection needs to be extended

imgresU.S. regulators and the drug industry want to extend by two months the deadline for the Food and Drug Administration to approve or reject new drugs.  The FDA said it would need an extra 60-day “filing date” before the clock starts ticking on its 10-month deadline to review new drugs, or six months for a priority review.  This means even less time on the market to recoup costs and is one of the reasons why new drug prices are going to continue to climb. Continue reading

Do patients want apps to remind them to stay compliant ?

misconceptionThere is a misconception within marketing that just because people are using a certain technology or going to a certain website that they want marketers to follow them there.  The rule seems to be for startups “build it, get a mass audience & then intrude and interrupt consumers when they are there”.  For pharma marketers agencies are trying tell them to “get into mobile marketing” because “mobile marketing is growing rapidly and is where the eyeballs are”.  This is far from reality and far from the truth. Continue reading